Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$33,285,098
+$12,272,529 QoQ
Shares Held
281,576
+68.6% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NATIXIS holds $42,325,153 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (78.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
281,576 | $33,285,098 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
85,200 | $4,403,988 | |
| 3 | VTRS |
Viatris Inc
|
134,531 | $1,817,513 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
34,000 | $768,400 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,175 | $696,751 | |
| 6 | EOLS |
Evolus, Inc.
|
141,437 | $581,306 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
13,589 | $409,300 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
2,647 | $348,715 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,285,098 | 281,576 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $21,012,569 | 167,005 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,013,213 | 75,268 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,662,028 | 42,719 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,980,830 | 42,398 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $9,723,825 | 59,681 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,608,727 | 33,825 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,752,496 | 10,109 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $36,781,854 | 217,374 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,212,984 | 56,812 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,732,377 | 73,183 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,292,004 | 199,129 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,177,087 | 37,113 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,250,929 | 110,890 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $10,321,725 | 69,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $60,391,316 | 351,337 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $60,207,168 | 319,249 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,164,128 | 45,749 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $50,006,775 | 257,581 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $29,832,223 | 189,435 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $25,194,065 | 152,230 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $10,122,959 | 61,214 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $61,763,379 | 450,696 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,361,910 | 96,541 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||